Should all stools be screened for Shiga toxin-producing Escherichia coli?

Journal of Clinical Microbiology

Volumn 49, Issue 7, 2011, Pages 2390-2397

  Kiska, Deanna L ^a   Riddell, Scott W ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VEROTOXIN 1; VEROTOXIN 2; VIRULENCE FACTOR; SHIGA TOXIN;

ANTIGEN DETECTION; BACTERIAL GASTROENTERITIS; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CULTURE MEDIUM; ENRICHMENT CULTURE; ENZYME IMMUNOASSAY; FECES ANALYSIS; GASTROENTERITIS; HUMAN; IMMUNOASSAY; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; REVIEW; SEROTYPING; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; STRAIN DIFFERENCE; TOXIN ANALYSIS; ARTICLE; CHEMISTRY; ECONOMICS; ESCHERICHIA COLI INFECTION; FECES; INCIDENCE; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MORTALITY; PRACTICE GUIDELINE; PREVALENCE; PUBLIC HEALTH SERVICE; UNITED STATES;

ESCHERICHIA COLI;

BACTERIOLOGICAL TECHNIQUES; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CULTURE MEDIA; ESCHERICHIA COLI INFECTIONS; FECES; GUIDELINE ADHERENCE; GUIDELINES AS TOPIC; HUMANS; IMMUNOASSAY; INCIDENCE; PREVALENCE; SHIGA TOXIN; SHIGA-TOXIGENIC ESCHERICHIA COLI; UNITED STATES;

EID: 79959815583     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00817-11     Document Type: Review

References (17)

1. Ake, J. A., et al. 2005. Nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 115:e673-e680.
2. CDC. 2001. University outbreak of calicivirus infection mistakenly attributed to Shiga toxin-producing Escherichia coli O157:H7 - Virginia, 2000. MMWR Morb. Mortal. Wkly. Rep. 50:489-491.
3. CDC. 2006. Importance of culture confirmation of Shiga toxin-producing Escherichia coli infection as illustrated by outbreaks of gastroenteritis - New York and North Carolina, 2005. MMWR Morb. Mortal. Wkly. Rep. 55:1042-1045.
4. CDC. 2009. Recommendations for diagnosis of Shiga toxin-producing Escherichia coli infections by clinical laboratories. MMWR Morb. Mortal. Wkly. Rep. 58:1-14.
5. Gavin, P. J., et al. 2004. Evaluation of performance and potential clinical impact of ProSpecT Shiga toxin Escherichia coli microplate assay for detection of Shiga toxin-producing E. coli in stool samples. J. Clin. Microbiol. 42:1652-1656.
6. Johnson, K. E., C. M. Thorpe, and C. L. Sears. 2006. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin. Infect. Dis. 43:1587-1595.
7. Lathrop, S., K., Edge, and J. Bareta. 2009. Shiga toxin-producing Escherichia coli, New Mexico, USA, 2004-2007. Emerg. Infect. Dis. 15:1289-1291.
8. Martin, D. L., K. L. MacDonald, K. E. White, J. T. Soler, and M. T. Osterholm. 1990. The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N. Engl. J. Med. 323:1161-1167.
9. Niaudet, P. 2010. Clinical manifestations and diagnosis of Shiga-like toxin associated (typical) hemolytic uremic syndrome in children. In T. J. Mattoo and S. L. Kaplan (ed.). UpToDate, Waltham, MA.
10. Nielsen, E. M., F. Scheutz, and M. Torpdahl. 2006. Continuous surveillance of Shiga toxin-producing Escherichia coli infections by pulsed-field gel electrophoresis shows that most infections are sporadic. Food Pathog. Dis. 3:81-87.
11. Panos, G. Z., G. I. Betsi, and M. E. Falagas. 2006. Are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection? Alim. Pharmacol. 24:731-742.
12. Parry, S. M., and S. R. Palmer. 2000. Public health significance of VTEC O157. J. Appl. Microbiol. 88:1S-9S.
13. Pollock, K. G. et al. 2009. From diarrhoea to haemolytic uraemic syndrome - when to seek advice. J. Med. Microbiol. 58:397-398.
14. Safdar, N., A. Said, R. E. Gangnon, and D. G. Maki,. 2002. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis. J. Am. Med. Assoc. 288:996-1001.
15. Snedeker, K. G., D. J. Shaw, M. E. Locking, and R. J. Prescott. 2009. Primary and secondary cases in Escherichia coli O157 outbreaks: a statistical analysis. BMC Infect. Dis. 9:144-154.
16. Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shiga toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073-1086.
17. Werber, D., B. W. Mason, M. R. Evans, and R. L. Salmon. 2008. Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be key. Clin. Infect. Dis. 46:1189-1196.